Brian Halliday

WORK HISTORY

EDUCATION

ABOUT BRIAN HALLIDAY

Brian is a Clinical Associate Professor and British Heart Foundation Intermediate Fellow at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist at Royal Brompton and Harefield Hospitals and Cleveland Clinic London.Clinically, he sees patients with all forms of cardiomyopathy (both NHS and private) and reports cardiovascular magnetic resonance. His research programme focuses on improving the treatment of patients with cardiomyopathy at different stages of disease. He designed and conducted the BHF funded TRED-HF trial that was published in The Lancet and investigated the safety of therapy withdrawal in recovered dilated cardiomyopathy. More recently he has received further BHF funding to perform a follow-on trial in the same patient group (TRED-HF-2) as well as a trial of a novel antioxidant (MitoQ) in persistent dilated cardiomyopathy. He is an expert in cardiovascular magnetic resonance and has an interest in identifying markers of disease in early cardiomyopathy with the aim of investigating therapies for disease prevention. He is an investigator on several industry sponsored trials in the field of cardiomyopathy and advises a number of pharmaceutical companies in this area.He engages with patients and the public about his research and was on the steering committee of the James Lind Alliance Priority Setting Partnership on cardiomyopathy. He is on the editorial board of the European Heart Journal and Circulation Cardiovascular Imaging, the European Society of Cardiology Programme Committee and the board and research committee of the British Society of Heart Failure. He is an academic tutor for Imperial medical students and module lead on the cardiovascular intercalated BSc programme. TrainingHe completed his undergraduate training at University of Edinburgh and was awarded the Murdoch Brown Silver Medal for Medicine, before moving to London to continue his clinical training at Royal Brompton and Harefield Hospitals and St George’s Hospital. He was awarded his PhD in 2018 under the supervision of Prof Sanjay Prasad and Prof John Cleland, along with the NHLI Prize for the Best Thesis. He won national and international young investigator awards for his research from the British Society of Heart Failure, the European Society of Cardiology Heart Failure Association and the American College of Cardiology. He was also awarded a grant from the European Society of Cardiology to complete a part-time MSc in Clinical Trials at the Nuffield Department of Public Health, University of Oxford.